IT·Science
Technology
'The Warring States Period of Insulin Pumps'… CareMedi, EOFlow Co., Ltd., and CureStream Clash
The domestic patch-type insulin pump market is entering a competitive phase. CareMedi’s CareRevo—the second domestically produced insulin pump to receive approval in five years—was recently launched, …
- 2026-06-30 08:21:02
- NA EUN-KYUNG
Technology
HLB PANAGENE Files Key AOC Patent Application and Is Selected for Government Support Program
HLB PANAGENE(046210)has further strengthened its intellectual property (IP) competitiveness in the field of antibody-oligonucleotide conjugates (AOCs)—which are gaining attention as next-generation th…
- 2026-06-30 08:20:03
- Kim Seung-kwon
Technology
Xcell Therapeutics Inc. to Develop Cell Therapy with “China’s Martin Evans,” a Nobel Laureate
#Xcell Therapeutics Inc. (hereinafter “Xcell”), a company specializing in chemically defined media for cell and gene therapies (CGT), announced on the 30th that it will embark on joint research and de…
- 2026-06-30 08:08:02
- Kim Seung-kwon
Internet
SHINSEGAE INFORMATION & COMMUNICATION Co.,Ltd Publishes Sustainability Report
SHINSEGAE INFORMATION & COMMUNICATION Co., Ltd. (#SHINSEGAE I&C Technology Co., Ltd.) announced on the 30th that it has published its fourth Sustainability Report and strengthened the disclosure of in…
- 2026-06-30 07:23:00
- Shin Yeong-bin
Gaming
NEXUS, Completes Acquisition of One Store… Secures 89.03% Stake for 626억
Action Square Co., Ltd.(205500)has completed the acquisition of the domestic app marketplace "OneStore."NEXUS announced on the 29th that it has completed the payment for the acquisition of 20,247,990 …
- 2026-06-29 18:23:41
- Lee So-Hyun
Telecommunications & Broadcasting
SKT Invests 3971억 in SK hynix’s U.S. NAND Subsidiary… Acquires 0.62% Stake
SKTelecom(017670)SK Group is investing approximately 3971억 won in #SK hynix’s U.S. NAND business subsidiary. This move is seen as an effort to strengthen semiconductor collaboration within the SK Grou…
- 2026-06-29 18:10:33
- Lee So-Hyun
Technology
Samsung Bioepis: “Phase 1 and 3 Clinical Trials Prove Equivalence of Keytruda Biosimilar”
Samsung Bioepis has become the first company to announce the results of its global Phase 3 clinical trial for a Keytruda biosimilar. This achievement comes amid fierce competition in the development o…
- 2026-06-29 17:02:02
- Hong Ju-yeon
Internet
"Pouring 1,000 trillion into the 'heart of AI'"... A bold move to build 18.4 GW of AI data centers nationwide
The government is positioning AI as a core pillar of its national growth strategy and is moving full steam ahead with the “Three Mega-Projects for Korea’s Great Leap Forward.” In particular, it has de…
- 2026-06-29 16:05:07
- Han Kwangbeom
Gaming
With Development Costs Soaring, Game Companies Turn to 'Classic' Titles for a Safe Formula for Success
Amid soaring development costs and a slowing game market, domestic game companies are focusing on releasing “classic” games based on proven intellectual property (IP). Moving beyond the trend of simpl…
- 2026-06-29 15:56:55
- An Yu-ri
Technology
BukwangPharmaceutical Launches First Collaboration Following Acquisition of UNION KOREA PHARM CO.,Ltd… Begins Full-Scale Contract Manufacturing
BukwangPharmaceutical(003000)announced on the 29th that it has shipped its first contract manufacturing (CMO) pharmaceutical product in collaboration with UNION KOREA PHARM CO.,Ltd(080720), marking th…
- 2026-06-29 15:11:02
- NA EUN-KYUNG
PHARM EDAILY
Shorts